2007Chinese Journal of Hospital PharmacyRequires access

Pharmacokinetic study of pazufloxacin mesylate in Chinese healthy volunteers

Junxian Yu

Open publisher page 0 citations

Abstract

OBJECTIVE To investigate the pharmacokinetics of pazufloxacin mesylate in Chinese healthy volunteers.METHODS Twelve healthy volunteers were received a single dose(300 mg),then multi-doses(300 mg bid)within 30 min intravenous infusion of pazufloxacin mesylate in an open randomized cross-over study.The plasma concentration of pazufloxacin were determined by HPLC-fluorescence.RESULTS The quantitation limit was 0.028 mg·L-1 The relative standard deviations for within-day and between-day were all 5%,And the recoveris were 90%.A good linearity was obtained from 0.028 to 14.50 mg·L-1.The results showed that the plasma concentration-time curve conformed to two compatment model.Pharmacokinetic profiles were fitted to an open two-compartment model analyzed by using 3P97.The mean pharmacokinetic parameters of singl dose and multi dose were:Cmax(7.2±0.8)mg·L-1 and(7.3±0.8)mg·L-1;t1/2(2.04±0.17)h and(2.24±0.23)h;AUC0-t(14.0±1.5)mg·h·L-1 and(13.1±1.5)mg·h·L-1;Vc(27.2±4.6)L and(25.3±8.8)L;CL(22.1±2.6)L·h-1 and(23.7±2.1)L·h-1,respectively.No significant diference existed between a single dose and multiple doses.but significant diffences of T1/2 and MRT occurred within man and fimale whether by a single dose or multiple doses.CONCLUSION Pazufloxacin mesylate is tolerant with a single dose or multi-doses.by intravenous infusion in Chinese healthy volunteers.No accumulation in the body was observed after 5 days administration.Significant diference in pharmacokinetic parameters such as t1/2 and MRT may be due to sex differenc.

About this research paper

What this paper is about

OBJECTIVE To investigate the pharmacokinetics of pazufloxacin mesylate in Chinese healthy volunteers.METHODS Twelve healthy volunteers were received a single dose(300 mg),then multi-doses(300 mg bid)within 30 min intravenous infusion of pazufloxacin mesylate in an open randomized cross-over study.The plasma concentration of pazufloxacin were determined by HPLC-fluorescence.RESULTS The quantitation limit was 0.028 mg·L-1 The relative standard deviations for within-day and between-day were all 5%,And the recoveris were 90%.A good linearity was obtained from 0.028 to 14.50 mg·L-1.The results showed that the plasma concentration-time curve conformed to two compatment model.Pharmacokinetic profiles were fitted to an open two-compartment model analyzed by using 3P97.The mean pharmacokinetic parameters of singl dose and multi dose were:Cmax(7.2±0.8)mg·L-1 and(7.3±0.8)mg·L-1;t1/2(2.04±0.17)h and(2.24±0.23)h;AUC0-t(14.0±1.5)mg·h·L-1 and(13.1±1.5)mg·h·L-1;Vc(27.2±4.6)L and(25.3±8.8)L;CL(22.1±2.6)L·h-1 and(23.7±2.1)L·h-1,respectively.No significant diference existed between a single dose and multiple doses.but significant diffences of T1/2 and MRT occurred within man and fimale whether by a single dose or multiple doses.CONCLUSION Pazufloxacin mesylate is tolerant with a single dose or multi-doses.by intravenous infusion in Chinese healthy volunteers.No accumulation in the body was observed after 5 days administration.Significant diference in pharmacokinetic parameters such as t1/2 and MRT may be due to sex differenc.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To investigate the pharmacokinetics of pazufloxacin mesylate in Chinese healthy volunteers.METHODS Twelve healthy volunteers were received a single dose(300 mg),then multi-doses(300 mg bid)within 30 min intravenous infusion of pazufloxacin mesylate in an open randomized cross-over study.The plasma concentration of pazufloxacin were determined by HPLC-fluorescence.RESULTS The quantitation limit was 0.028 mg·L-1 The relative standard deviations for within-day and between-day were all 5%,And the recoveris were 90%.A good linearity was obtained from 0.028 to 14.50 mg·L-1.The results showed that the plasma concentration-time curve conformed to two compatment model.Pharmacokinetic profiles were fitted to an open two-compartment model analyzed by using 3P97.The mean pharmacokinetic parameters of singl dose and multi dose were:Cmax(7.2±0.8)mg·L-1 and(7.3±0.8)mg·L-1;t1/2(2.04±0.17)h and(2.24±0.23)h;AUC0-t(14.0±1.5)mg·h·L-1 and(13.1±1.5)mg·h·L-1;Vc(27.2±4.6)L and(25.3±8.8)L;CL(22.1±2.6)L·h-1 and(23.7±2.1)L·h-1,respectively.No significant diference existed between a single dose and multiple doses.but significant diffences of T1/2 and MRT occurred within man and fimale whether by a single dose or multiple doses.CONCLUSION Pazufloxacin mesylate is tolerant with a single dose or multi-doses.by intravenous infusion in Chinese healthy volunteers.No accumulation in the body was observed after 5 days administration.Significant diference in pharmacokinetic parameters such as t1/2 and MRT may be due to sex differenc.

Key concepts: Pharmacokinetics, Cmax, Pharmacology, Chemistry, Mesylate, Chromatography, Plasma concentration, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetic study of pazufloxacin mesylate in Chinese healthy volunteers — Research Paper | ScholarLens